vs

Side-by-side financial comparison of Bank First Corp (BFC) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $44.9M, roughly 1.9× Bank First Corp). Bank First Corp runs the higher net margin — 45.8% vs 22.8%, a 23.0% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 12.1%). Bank First Corp produced more free cash flow last quarter ($51.0M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 9.1%).

First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

BFC vs FDMT — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.9× larger
FDMT
$85.1M
$44.9M
BFC
Growing faster (revenue YoY)
FDMT
FDMT
+8508887.9% gap
FDMT
8508900.0%
12.1%
BFC
Higher net margin
BFC
BFC
23.0% more per $
BFC
45.8%
22.8%
FDMT
More free cash flow
BFC
BFC
$22.6M more FCF
BFC
$51.0M
$28.5M
FDMT
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
9.1%
BFC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BFC
BFC
FDMT
FDMT
Revenue
$44.9M
$85.1M
Net Profit
$18.4M
$19.4M
Gross Margin
Operating Margin
51.0%
17.3%
Net Margin
45.8%
22.8%
Revenue YoY
12.1%
8508900.0%
Net Profit YoY
4.8%
139.1%
EPS (diluted)
$1.87
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFC
BFC
FDMT
FDMT
Q4 25
$44.9M
$85.1M
Q3 25
$44.2M
$90.0K
Q2 25
$41.6M
$15.0K
Q1 25
$43.1M
$14.0K
Q4 24
$40.1M
$1.0K
Q3 24
$40.8M
$3.0K
Q2 24
$38.9M
$5.0K
Q1 24
$37.7M
$28.0K
Net Profit
BFC
BFC
FDMT
FDMT
Q4 25
$18.4M
$19.4M
Q3 25
$18.0M
$-56.9M
Q2 25
$16.9M
$-54.7M
Q1 25
$18.2M
$-48.0M
Q4 24
$17.5M
Q3 24
$16.6M
$-43.8M
Q2 24
$16.1M
$-35.0M
Q1 24
$15.4M
$-32.4M
Operating Margin
BFC
BFC
FDMT
FDMT
Q4 25
51.0%
17.3%
Q3 25
50.8%
-67983.3%
Q2 25
49.7%
-396373.3%
Q1 25
51.3%
-383007.1%
Q4 24
54.4%
Q3 24
50.7%
-1704400.0%
Q2 24
51.0%
-849120.0%
Q1 24
45.6%
-136200.0%
Net Margin
BFC
BFC
FDMT
FDMT
Q4 25
45.8%
22.8%
Q3 25
40.7%
-63195.6%
Q2 25
40.5%
-364386.7%
Q1 25
42.3%
-342657.1%
Q4 24
49.3%
Q3 24
40.6%
-1461433.3%
Q2 24
41.3%
-699060.0%
Q1 24
40.8%
-115717.9%
EPS (diluted)
BFC
BFC
FDMT
FDMT
Q4 25
$1.87
$0.43
Q3 25
$1.83
$-1.01
Q2 25
$1.71
$-0.98
Q1 25
$1.82
$-0.86
Q4 24
$1.75
Q3 24
$1.65
$-0.79
Q2 24
$1.59
$-0.63
Q1 24
$1.51
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFC
BFC
FDMT
FDMT
Cash + ST InvestmentsLiquidity on hand
$243.2M
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$643.8M
$505.7M
Total Assets
$4.5B
$566.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFC
BFC
FDMT
FDMT
Q4 25
$243.2M
$402.7M
Q3 25
$126.2M
$305.1M
Q2 25
$120.3M
$293.2M
Q1 25
$300.9M
$321.4M
Q4 24
$261.3M
$424.9M
Q3 24
$204.4M
$501.9M
Q2 24
$99.0M
$541.9M
Q1 24
$83.4M
$525.9M
Stockholders' Equity
BFC
BFC
FDMT
FDMT
Q4 25
$643.8M
$505.7M
Q3 25
$628.1M
$369.0M
Q2 25
$612.3M
$420.9M
Q1 25
$648.4M
$469.7M
Q4 24
$639.7M
$510.6M
Q3 24
$628.9M
$552.9M
Q2 24
$614.6M
$588.3M
Q1 24
$609.3M
$600.6M
Total Assets
BFC
BFC
FDMT
FDMT
Q4 25
$4.5B
$566.7M
Q3 25
$4.4B
$424.0M
Q2 25
$4.4B
$473.6M
Q1 25
$4.5B
$515.7M
Q4 24
$4.5B
$560.4M
Q3 24
$4.3B
$604.0M
Q2 24
$4.1B
$620.1M
Q1 24
$4.1B
$629.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFC
BFC
FDMT
FDMT
Operating Cash FlowLast quarter
$62.5M
$28.6M
Free Cash FlowOCF − Capex
$51.0M
$28.5M
FCF MarginFCF / Revenue
113.6%
33.5%
Capex IntensityCapex / Revenue
25.5%
0.1%
Cash ConversionOCF / Net Profit
3.40×
1.47×
TTM Free Cash FlowTrailing 4 quarters
$75.8M
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFC
BFC
FDMT
FDMT
Q4 25
$62.5M
$28.6M
Q3 25
$15.5M
$-46.5M
Q2 25
$11.9M
$-43.4M
Q1 25
$6.2M
$-47.8M
Q4 24
$65.8M
$-134.6M
Q3 24
$18.8M
$-29.4M
Q2 24
$14.9M
$-30.2M
Q1 24
$1.3M
$-29.1M
Free Cash Flow
BFC
BFC
FDMT
FDMT
Q4 25
$51.0M
$28.5M
Q3 25
$12.5M
$-46.6M
Q2 25
$8.2M
$-43.4M
Q1 25
$4.0M
$-48.4M
Q4 24
$58.6M
$-138.4M
Q3 24
$16.9M
$-31.2M
Q2 24
$13.7M
$-30.6M
Q1 24
$551.0K
$-29.8M
FCF Margin
BFC
BFC
FDMT
FDMT
Q4 25
113.6%
33.5%
Q3 25
28.2%
-51765.6%
Q2 25
19.8%
-289620.0%
Q1 25
9.3%
-345635.7%
Q4 24
146.3%
-13837100.0%
Q3 24
41.5%
-1038966.7%
Q2 24
35.3%
-611840.0%
Q1 24
1.5%
-106421.4%
Capex Intensity
BFC
BFC
FDMT
FDMT
Q4 25
25.5%
0.1%
Q3 25
6.7%
101.1%
Q2 25
8.7%
440.0%
Q1 25
5.0%
4507.1%
Q4 24
18.0%
378600.0%
Q3 24
4.5%
59266.7%
Q2 24
3.1%
6980.0%
Q1 24
2.1%
2535.7%
Cash Conversion
BFC
BFC
FDMT
FDMT
Q4 25
3.40×
1.47×
Q3 25
0.86×
Q2 25
0.70×
Q1 25
0.34×
Q4 24
3.75×
Q3 24
1.13×
Q2 24
0.93×
Q1 24
0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons